Crucial Roles of the Protein Kinases MK2 and MK3 in a Mouse Model of Glomerulonephritis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Guess, Adam J ^a   Ayoob, Rose ^a   Chanley, Melinda ^a   Manley, Joshua ^a   Cajaiba, Mariana M ^b   Agrawal, Shipra ^a   Pengal, Ruma ^a   Pyle, Amy L ^b   Becknell, Brian ^a   Kopp, Jeffrey B ^c   Ronkina, Natalia ^d   Gaestel, Matthias ^d   Benndorf, Rainer ^a,e   Smoyer, William E ^a,e  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN B6; HEAT SHOCK PROTEIN B8; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE; PROTEIN KINASE MK2; PROTEIN KINASE MK3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF 2; UNCLASSIFIED DRUG;

ACUTE PROLIFERATIVE GLOMERULONEPHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; FEMALE; GENE; GENE DOSAGE; GENOTYPE; HISTOPATHOLOGY; KIDNEY CORTEX; KIDNEY FUNCTION TEST; KIDNEY INJURY; MALE; MK2 GENE; MK3 GENE; MORTALITY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ACUTE DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GLOMERULONEPHRITIS; HEAT-SHOCK PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY FUNCTION TESTS; MICE; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

ANIMALIA; MUS;

EID: 84872781838     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054239     Document Type: Article

References (43)

1. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, et al. (2009) Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol 296: F213-229.
2. Yo Y, Braun MC, Barisoni L, Mobaraki H, Lu H, et al. (2003) Anti-mouse mesangial cell serum induces acute glomerulonephropathy in mice. Nephron Exp Nephrol 93: e92-106.
3. Cuenda A, Rousseau S, (2007) p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 1773: 1358-1375.
4. Ronkina N, Menon MB, Schwermann J, Tiedje C, Hitti E, et al. (2010) MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin. Biochem Pharmacol 80: 1915-1920.
5. Gaestel M, Mengel A, Bothe U, Asadullah K, (2007) Protein kinases as small molecule inhibitor targets in inflammation. Curr Med Chem 14: 2214-2234.
6. Ronkina N, Kotlyarov A, Dittrich-Breiholz O, Kracht M, Hitti E, et al. (2007) The mitogen-activated protein kinase (MAPK)-activated protein kinases MK2 and MK3 cooperate in stimulation of tumor necrosis factor biosynthesis and stabilization of p38 MAPK. Mol Cell Biol 27: 170-181.
7. Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, et al. (2005) Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 16: 2690-2701.
8. Sheryanna A, Bhangal G, McDaid J, Smith J, Manning A, et al. (2007) Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6. J Am Soc Nephrol 18: 1167-1179.
9. Polzer K, Soleiman A, Baum W, Axmann R, Distler J, et al. (2008) Selective p38MAPK isoform expression and activation in antineutrophil cytoplasmatic antibody-associated crescentic glomerulonephritis: role of p38MAPKalpha. Ann Rheum Dis 67: 602-608.
10. Stambe C, Atkins RC, Hill PA, Nikolic-Paterson DJ, (2003) Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis. Kidney Int 64: 2121-2132.
11. Stambe C, Atkins RC, Tesch GH, Kapoun AM, Hill PA, et al. (2003) Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis. J Am Soc Nephrol 14: 338-351.
12. Stambe C, Nikolic-Paterson DJ, Hill PA, Dowling J, Atkins RC, (2004) p38 Mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury. J Am Soc Nephrol 15: 326-336.
13. Pengal R, Guess AJ, Agrawal S, Manley J, Ransom RF, et al. (2011) Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury. Am J Physiol Renal Physiol 301: F509-519.
14. Ronkina N, Kotlyarov A, Gaestel M, (2008) MK2 and MK3-a pair of isoenzymes? Front Biosci 13: 5511-5521.
15. Gaestel M, (2006) MAPKAP kinases- MKs- two's company, three's a crowd. Nat Rev Mol Cell Biol 7: 120-130.
16. Ehlting C, Ronkina N, Bohmer O, Albrecht U, Bode KA, et al. (2011) Distinct functions of the mitogen-activated protein kinase-activated protein (MAPKAP) kinases MK2 and MK3: MK2 mediates lipopolysaccharide-induced signal transducers and activators of transcription 3 (STAT3) activation by preventing negative regulatory effects of MK3. J Biol Chem 286: 24113-24124.
17. Gaestel M, (2008) Specificity of signaling from MAPKs to MAPKAPKs: kinases' tango nuevo. Front Biosci 13: 6050-6059.
18. Gaestel M, Schroder W, Benndorf R, Lippmann C, Buchner K, et al. (1991) Identification of the phosphorylation sites of the murine small heat shock protein hsp25. J Biol Chem 266: 14721-14724.
19. Clifton AD, Young PR, Cohen P, (1996) A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress. FEBS Lett 392: 209-214.
20. Shiryaev A, Moens U, (2010) Mitogen-activated protein kinase p38 and MK2, MK3 and MK5: menage a trois or menage a quatre? Cell Signal 22: 1185-1192.
21. Shiryaev A, Dumitriu G, Moens U, (2011) Distinct roles of MK2 and MK5 in cAMP/PKA- and stress/p38MAPK-induced heat shock protein 27 phosphorylation. J Mol Signal 6: 4.
22. Smoyer WE, Ransom R, Harris RC, Welsh MJ, Lutsch G, et al. (2000) Ischemic acute renal failure induces differential expression of small heat shock proteins. J Am Soc Nephrol 11: 211-221.
23. Smoyer WE, Ransom RF, (2002) Hsp27 regulates podocyte cytoskeletal changes in an in vitro model of podocyte process retraction. FASEB J 16: 315-326.
24. Hirano S, Sun X, DeGuzman CA, Ransom RF, McLeish KR, et al. (2005) p38 MAPK/HSP25 signaling mediates cadmium-induced contraction of mesangial cells and renal glomeruli. Am J Physiol Renal Physiol 288: F1133-1143.
25. Sanchez-Nino MD, Sanz AB, Sanchez-Lopez E, Ruiz-Ortega M, Benito-Martin A, et al. (2012) HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II. Lab Invest 92: 32-45.
26. Kampinga HH, (2006) Chaperones in preventing protein denaturation in living cells and protecting against cellular stress. Handb Exp Pharmacol pp. 1-42.
27. Markan S, Kohli HS, Joshi K, Minz RW, Sud K, et al. (2009) Up regulation of the GRP-78 and GADD-153 and down regulation of Bcl-2 proteins in primary glomerular diseases: a possible involvement of the ER stress pathway in glomerulonephritis. Mol Cell Biochem 324: 131-138.
28. Cybulsky AV, Kennedy CR, (2011) Podocyte Injury Associated with Mutant alpha-Actinin-4. J Signal Transduct 2011: 563128.
29. Ito N, Nishibori Y, Ito Y, Takagi H, Akimoto Y, et al. (2011) mTORC1 activation triggers the unfolded protein response in podocytes and leads to nephrotic syndrome. Lab Invest 91: 1584-1595.
30. Iwata J, Nishikaze O, (1979) New micro-turbidimetric method for determination of protein in cerebrospinal fluid and urine. Clin Chem 25: 1317-1319.
31. Robertson D, Savage K, Reis-Filho JS, Isacke CM, (2008) Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue. BMC Cell Biol 9: 13.
32. Benndorf R, Engel K, Gaestel M, (2000) Analysis of small Hsp phosphorylation. Methods Mol Biol 99: 431-445.
33. Yoshida S, Nagase M, Shibata S, Fujita T, (2008) Podocyte injury induced by albumin overload in vivo and in vitro: involvement of TGF-beta and p38 MAPK. Nephron Exp Nephrol 108: e57-68.
34. Park JK, Ronkina N, Hoft A, Prohl C, Menne J, et al. (2008) Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy. Nephrol Dial Transplant 23: 1844-1853.
35. Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, et al. (2005) Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 16: 1733-1741.
36. Milovanceva-Popovska M, Kunter U, Ostendorf T, Petermann A, Rong S, et al. (2005) R-roscovitine (CYC202) alleviates renal cell proliferation in nephritis without aggravating podocyte injury. Kidney Int 67: 1362-1370.
37. Musial K, Zwolinska D, (2011) Heat shock proteins in chronic kidney disease. Pediatr Nephrol 26: 1031-1037.
38. Dousa TP, (1999) Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int 55: 29-62.
39. Anderson DR, Meyers MJ, Vernier WF, Mahoney MW, Kurumbail RG, et al. (2007) Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2). J Med Chem 50: 2647-2654.
40. Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ, (1997) Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386: 296-299.
41. Murea M, Park JK, Sharma S, Kato H, Gruenwald A, et al. (2010) Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function. Kidney Int 78: 514-522.
42. Menne J, Park JK, Boehne M, Elger M, Lindschau C, et al. (2004) Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. Diabetes 53: 2101-2109.
43. Huber TB, Walz G, Kuehn EW, (2011) mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression. Kidney Int 79: 502-511.